# N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement

> **NCT06486805** · PHASE4 · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 54 (actual)

## Conditions studied

- Oxidative Stress
- Liver Dysfunction

## Interventions

- **DRUG:** N acetyl cysteine
- **OTHER:** normal saline

## Key facts

- **NCT ID:** NCT06486805
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-30
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06486805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06486805, "N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06486805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*